Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

British Journal of Cancer
Y H ParkY-H Im

Abstract

The aim of this study was to investigate the role of human epidermal growth factor receptor (HER3) and PTEN expression in patients with HER2-overexpressing metastatic breast cancer (MBC). One hundred twenty-five MBC patients who were treated with taxane plus trastuzumab chemotherapy as first-line therapy were included in this analysis. Immunohistochemical (IHC) staining with HER3 and PTEN antibodies were conducted retrospectively. Patients who had negative HER3 staining (62.4%) had a better progression-free survival (PFS) than did those who had positive HER3 staining (P=0.001; median PFS, 21 vs 11 months). Patients who had a PTEN score >20 (78.1%) showed longer PFS than did those with a PTEN score ≤20 (P=0.006; median PFS, 13 vs 9 months). Patients who had a PTEN score >20 exhibited a longer overall survival (OS) than did those with a PTEN score ≤20 (P=0.005; median OS, 48 vs 25 months). HER3 negativity and PTEN loss were identified as independent risk factors for PFS. PTEN loss was identified as an independent risk factor for OS. HER3 and PTEN expressions may be predictive markers, and PTEN expression may be a predictive and prognostic biomarker for trastuzumab treatment in HER2-positive MBCs.

References

Dec 1, 1992·British Journal of Cancer·N R LemoineH C Hurst
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G GaspariniP Bevilacqua
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·Y Yarden, M X Sliwkowski
Mar 22, 2003·Experimental Cell Research·Ami CitriYosef Yarden
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thomas HolbroNancy E Hynes
Jul 17, 2003·International Journal of Cancer. Journal International Du Cancer·Ivan BiècheRosette Lidereau
Jun 29, 2004·Seminars in Cancer Biology·Yaron Mosesson, Yosef Yarden
Jul 15, 2005·The New England Journal of Medicine·Daniela S Krause, Richard A Van Etten
Aug 18, 2005·Journal of the National Cancer Institute·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
May 10, 2006·Nature Clinical Practice. Oncology·Rita NahtaFrancisco J Esteva
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Jan 10, 2008·Breast Cancer Research : BCR·Andrea SassenGero Brockhoff
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jul 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Siyuan Zhang, Dihua Yu
Oct 19, 2011·Cancer·Edith A Perez, Jean-Philippe Spano
Nov 30, 2011·Nature Reviews. Clinical Oncology·Carlos L ArteagaLuca Gianni
Jun 30, 2012·Virchows Archiv : an International Journal of Pathology·Mattia BarbareschiPaolo Dalla Palma
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezMonica M Reinholz

❮ Previous
Next ❯

Citations

May 2, 2014·International Journal of Medical Sciences·Mohammad FirooziniaHabsah Abdul Kadir
May 26, 2016·Breast Cancer Research : BCR·Maria Peiris-PagèsMichael P Lisanti
Oct 14, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ling MaoJin-Hai Tang
Feb 22, 2017·Pharmacology & Therapeutics·Nandini DeyBrian Leyland-Jones
Jul 9, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Satu LuhtalaJorma Isola
Mar 27, 2018·The Journal of Pharmacy and Pharmacology·Shima Moradi-KalbolandiLeila Farahmand
Mar 18, 2015·Biomedical Optics Express·Simon P PolandSimon M Ameer-Beg
Feb 24, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel E Carvajal-HausdorfDavid L Rimm
Feb 28, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·José BaselgaMark D Pegram
Feb 9, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R CostaF J Giles
Oct 9, 2021·Chinese Medical Journal·Zi-Nan LuGang Sun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.